Pediatric Exclusivity Bill Expected To Be Signed Into Law By Year-End
This article was originally published in The Tan Sheet
Executive Summary
Legislation reauthorizing the pediatric exclusivity provisions of the FDA Modernization Act will close a loophole involving incidents where 180-day generic exclusivity and pediatric exclusivity overlap